Searchable abstracts of presentations at key conferences in endocrinology

ea0005p184 | Neuroendocrinology and Behaviour | BES2003

Differential effects of the route of testosterone administration on GH sensitivity and bone mineral density in hypopituitarism

Brooke A , Carroll P , Walker D , Besser G , Monson J

The route of oestrogen replacement has an important influence on growth hormone (GH) sensitivity, but it remains unclear whether the route of testosterone treatment in hypopituitarism influences the response to GH replacement. We have compared IGF-I levels, body composition and BMD in hypopituitary male patients with severe GH-deficiency receiving either oral testosterone undecanoate (T.U.)(80-160 milligrams per day) or intramuscular testosterone (I.M.) (250-500 milligrams per...

ea0042oc14 | (1) | Androgens2016

Optimization of an engineered microrepressor for the treatment of castration-resistant prostate cancer

Fioretti Flavia Marialucia , Lai Chun Fui , Powell Sue , Ali Simak , Brooke Greg N. , Bevan Charlotte

Prostate cancer is currently treated with hormonal therapies, which aim to block the production and/or action of androgens. However, tumours eventually progress to castration-resistant prostate cancer and there is a great need for new therapeutic approaches. We have designed and tested engineered repressors which could be effective in circumstances where current therapies fail. These consist of two modules: an interaction domain, which binds directly to the androgen receptor (...

ea0059p137 | Neuroendocrinology and pituitary | SFEBES2018

Safety of prescribing for inpatients with cranial diabetes insipidus (CDI): a Southwest Peninsula Audit

Edeghere Simon , Morton Claire , Rogers Sue , Babiker Tarig , Elzain Yamin , Brooke Antonia , Network Peninsula Endocrine

Cranial Diabetes Insipidus (CDI) is associated with significant polyuria and is treated with desmopressin. Inappropriate or missed treatment can result in significant electrolyte imbalance and potential harm. A recent UK survey of Endocrinologists reported 55% had concerns about knowledge in their trust, 39% felt they had observed patients come to harm. Patients not receiving desmopressin have been associated with death, leading to an NHS England (NHSE) safety alert in 2016. W...

ea0038p317 | Pituitary | SFEBES2015

Patient experiences of living with acromegaly in the UK

Brooke Antonia , Lyttle Jacqui , Goss Lynne , Pobereskin Lou , Peninsula Endocrinology Network

61 patients (104 invited participants), within 10 years of active treatment for acromegaly, from five hospitals in the UK (one neurosurgical centre) were interviewed to explore the experience of living with acromegaly, access to information, support and their ability to make decisions about their care. Semi-structured interviews by an independent consultant (60–120 min each) included 34 males, 27 females; 25–85 years old; 85% patients had surgery. 56 (92%) experience...

ea0037gp.19.07 | Pituitary–Acromegaly | ECE2015

Patient experience of living with acromegaly in the UK

Brooke Antonia , Lyttle Jacqui , Goss Lynne , Pobereskin Louis , South West Peninsula Endocrinology Network

61 patients (104 invited participants), within 10 years of active treatment for acromegaly, from five hospitals in the South West Peninsula (UK) (one neurosurgical centre) were interviewed to explore the experience of living with acromegaly, access to information, support and their ability to make decisions about their care. Semi-structured interviews by an independent consultant (60–120 min each) included 34 males and 27 females; 25–85 years old; 52 (85%) patients h...

ea0034p366 | Steroids | SFEBES2014

Testosterone regulates glucose control in liver and muscle of Tfm mice as a mechanism to improve type 2 diabetes

Kelly Daniel , Akhtar Samia , Muraleedharan Vakkat , Sellers Donna , Brooke Johnathan , McLaren David , Jones Hugh

Introduction: There is a strong association between testosterone deficiency and the incidence of type 2 diabetes (T2D) in men. Physiological testosterone replacement (TRT) improves insulin resistance and glycaemic control in hypogonadal men. The mechanism by which testosterone mediates these beneficial actions are unknown but may be due to an effect on major metabolically active tissues such as liver and muscle. This study investigates the expression of key regulatory targets ...

ea0032p174 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2013

Testosterone differentially regulates liver X receptor expression and targets of lipid and glucose metabolism in liver, muscle and adipose tissue of the testicular feminised mouse

Kelly Daniel , Akhtar Samia , Muraleedharan Vakkat , Brooke Johnathan , McLaren David , Channer Kevin , Jones T Hugh

Testosterone deficiency increases risk for cardiovascular disease (CVD) and type 2 diabetes. Testosterone replacement (TRT) improves insulin resistance, glycaemic control and cholesterol in hypogonadal men. Liver X receptor (LXR) is a nuclear receptor which regulates lipid and glucose metabolism. LXR agonists protect against atherosclerosis but cause hepatic steatosis. We have previously shown that TRT protects against hepatic steatosis and atherosclerosis in high-fat diet-fed...

ea0028p182 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

Testosterone Inhibits Key Enzymes of Fatty Acid Synthase and Protects Against Hepatic Steatosis in the Tfm Mouse

Kelly Daniel , Brooke Jonathan , Muraleedharan Vakkat , Akhtar Samia , Channer Kevin , Jones Hugh

Objectives: A clinical feature of insulin resistance is the development of fatty liver (hepatic steatosis). Testosterone deficiency is common in men with type-2 diabetes and is associated with insulin resistance. The testicular feminised mouse (Tfm) exhibits a non-functional androgen receptor (AR) and low circulating testosterone. We have previously shown that a high-cholesterol diet promotes hepatic steatosis in Tfm mice, and testosterone replacement therapy (TRT) attenuates ...

ea0025p152 | Diabetes, metabolism and cardiovascular | SFEBES2011

Low testosterone and severity of erectile dysfunction (ED) are independently associated with poor health related quality of life (HRQoL) in men with type 2 diabetes

Brooke Jonathan , Walter Debbie , Muraleedharan Vakkat , Marsh Hazel , Kapoor Dheeraj , Jones T Hugh

Introduction: Both low testosterone levels and erectile dysfunction (ED) are highly prevalent in men with type 2 diabetes. Lower testosterone levels are known to be associated with worsening severity of ED as assessed using the International Index of Erectile Function score (IIEF). Testosterone deficiency and erectile dysfunction are both independently correlated with increased risk of cardiovascular disease.Aim: To investigate the effect of low testoste...

ea0021p115 | Clinical practice/governance and case reports | SFEBES2009

Endocrinopathy and low bone mineral density in thalassaemia

Waterhouse Mona , Gorrigan Rebecca , Thomas Aldine , Brooke Antonia , Telfer Paul , Kaya Banu , Akker Scott

Thalassaemia patients are transfusion dependent and at risk of iron overload with end organ damage. Iron deposition is reduced by chelation treatment. We present the data on endocrinopathy and bone density in the adult patients under our care with thalassaemia. In addition, we will discuss therapeutic approaches to these problems including the use of newer chelation agents and possible reversal of endocrine end organ damage. We will also review the correlation in our patients ...